Associations of Circulating Methylmalonic Acid and Vitamin B-12 Biomarkers Are Modified by Vegan Dietary Pattern in Adult and Elderly Participants of the Adventist Health Study 2 Calibration Study

Ella H Haddad; Karen Jaceldo-Siegl; Keiji Oda; Gary E Fraser

doi:10.1093/cdn/nzaa008

. 2020 Jan 22;4(2):nzaa008. doi: 10.1093/cdn/nzaa008

Associations of Circulating Methylmalonic Acid and Vitamin B-12 Biomarkers Are Modified by Vegan Dietary Pattern in Adult and Elderly Participants of the Adventist Health Study 2 Calibration Study

Ella H Haddad ^1,^✉, Karen Jaceldo-Siegl ¹, Keiji Oda ¹, Gary E Fraser ¹

PMCID: PMC7010841 PMID: 32064447

ABSTRACT

Background

Elevated plasma methylmalonic acid (MMA) is a functional biomarker of vitamin B-12 status but limited information is available on its prevalence in US vegetarians.

Objectives

The study examines the prevalence of plasma MMA ≥0.27 µmol/L in those consuming vegetarian diets, its associations with vitamin B-12 intake and biomarkers, and the modifying effect of vegetarian patterns on these associations.

Methods

In this cross-sectional study (n = 785), concentrations of MMA, vitamin B-12, holotranscobalamin (holoTC), and homocysteine (Hcy) were determined in participants of the calibration substudy of the Adventist Health Study 2 (AHS-2). Vitamin B-12 intake from food, fortified food, and supplements was assessed by six 24-h recalls. Regression models were used to estimate ORs of having high MMA as related to vitamin B-12 status biomarkers, vitamin B-12 intake, and dietary pattern.

Results

The prevalence of low vitamin B-12 status defined by serum vitamin B-12 <148 pmol/L, holoTC <35 pmol/L, MMA ≥0.27 and ≥0.37 μmol/L, or Hcy ≥15 μmol/L, and the OR of having high MMA did not differ by dietary pattern, possibly due to intake from fortified food and supplements. Total daily vitamin B-12 intake in the second tertile range of 4.4–14.5 μg/d reduced the likelihood of elevated MMA by 69%; and a doubling of vitamin B-12 intake was associated with a 4.3% decrease in plasma MMA. The association between log plasma MMA and biomarkers was modified by diet, with the vegan pattern showing an ∼3-fold stronger association with log serum vitamin B-12 and Hcy than did the nonvegetarian pattern.

Conclusions

The prevalence of vitamin B-12 intake <2.0 μg/d was 15.2% in vegans, 10.6% in lacto-ovo-vegetarians, and 6.5% in nonvegetarians. Given the irreversible neurological consequences of vitamin B-12 inadequacy, the importance of regular supplemental vitamin B-12 intake in adult and elderly individuals is stressed.

Keywords: vegetarian, vegan, methylmalonic acid, serum vitamin B-12, vitamin B-12 biomarkers, vitamin B-12 intake

Introduction

Owing to exclusion from the diet of meat and fish by lacto-ovo-vegetarians, and all animal products by vegans, the nutrient deficit most often associated with vegetarian eating is that of vitamin B-12. The consequences of vitamin B-12 (cobalamin) deficiency include neurologic damage and cognitive impairment which may not be fully reversible (1, 2). Of microbial origin and found in adequate quantities only in foods of animal origin, vitamin B-12 is involved in one-carbon pathways essential for methylation of DNA, histones, and other regulators of gene expression critical for normal hematologic and neurologic function (3). Vitamin B-12 as adenosylcobalamin is a cofactor for methyl CoA-mutase which converts methylmalonyl CoA to succinyl CoA and impaired activity of the enzyme leads to elevations of methylmalonic acid (MMA) (4). Because low serum vitamin B-12 concentration is not always reflective of poor status, elevated plasma MMA is employed as a functional biomarker of deficiency (4, 5). Although mechanisms explaining the etiology of cellular and neurologic manifestations accompanying vitamin B-12 deficiency are unclear, some evidence points to impaired methylation patterns and to the inflammatory and oxidative effects of elevated MMA as factors in the neurodegeneration and renal insufficiency which develop (6, 7). Along with inadequate vitamin B-12 intake, increased plasma MMA can arise from malabsorption and other gastrointestinal disorders, or from polymorphisms and genetic abnormalities (8).

Currently vegetarian and plant-based eating is promoted to lower risk of coronary artery disease and type 2 diabetes (9–11). In addition to an emphasis on consuming plant foods, these regimens promote restriction or avoidance of animal source foods. As a consequence, nutrient shortfalls, particularly those of vitamin B-12, must be considered. Vegetarians and persons adhering to plant-based eating may be at risk of inadequate intake unless they regularly consume vitamin B-12–fortified foods and vitamin B-12–containing supplements. This risk may be greater for elderly vegetarians owing to poor oral intake or owing to malabsorption which often arises from age-associated impairment in gastric acid secretion and gastrointestinal disturbances (12–14). Medications such as proton pump inhibitors, H2 receptor antagonists, and oral antidiabetic drugs may also contribute to malabsorption of the vitamin (15).

Studies examining vitamin B-12 status in vegetarians report high rates of depletion. In a systematic review of studies utilizing serum vitamin B-12 concentrations as a biomarker, Pawlak et al. (16) reported worldwide low vitamin B-12 status prevalence rates in adult and elderly vegetarians of ≤85%. In the European Prospective Investigation into Cancer and Nutrition Oxford cohort, Gilsing et al. (17) classified 52% of vegans and 7% of vegetarians as vitamin B-12 deficient, defined as serum vitamin B-12 <118 pmol/L. The prevalence of vitamin B-12 deficiency assessed as plasma MMA >0.27 μmol/L in the NHANES population is relatively low and increases with age, affecting 3.9% of those aged 19–39 y old, 5.1% of those 40–59 y old, and 15.9% of those >60 y old (18). Compared with nonvegetarians, more frequent elevated plasma MMA has been reported among vegetarian adults in Spain (19), preadolescent refugee girls in India (20), reproductive-age women in Nepal (21), and pregnant women in Canada (22). However, despite its importance in detecting functional vitamin B-12 abnormalities, studies using plasma MMA as a biomarker in US vegetarians have been limited to small sample sizes and to macrobiotic and vegan groups (23–25).

In healthy adults, plasma MMA concentrations are associated with age, creatinine concentrations, sex, dietary vitamin B-12 intake (26–28), and race (28). Plasma MMA concentrations are negatively associated with serum vitamin B-12 and with holotranscobalamin (holoTC), the fraction of the circulating vitamin B-12 taken up by cells, and positively with the metabolite homocysteine (Hcy). The modifying effect of vegetarian dietary patterns on these associations has not been examined. As the quantity of animal food in the diet decreases, so does natural-source vitamin B-12, leading to a greater dependence on fortified products and vitamin B-12–containing supplements which may not be sufficiently or regularly consumed. Also, vegetarian and plant-rich diets are high in folate and folate concentrations are known to affect vitamin B-12 metabolism. It is therefore important to establish whether vegetarian dietary patterns influence plasma MMA concentrations, particularly in older individuals.

To address this knowledge gap, the current study was designed to investigate clinical and dietary factors associated with likelihood of elevated MMA in adult-to-elderly participants of the Adventist Health Study 2 (AHS-2) calibration substudy. In addition to the population comprising many vegans and lacto-ovo-vegetarians with consistent dietary habits, the nonvegetarians in the population consume small to moderate amounts of dairy foods and meats (29, 30). In this study we aimed to compare the prevalence of elevated plasma MMA in individuals adhering to vegan, lacto-ovo-vegetarian, and nonvegetarian dietary patterns and the associations of dietary pattern, vitamin B-12 intake, and vitamin B-12–related biomarkers with circulating MMA. In addition we sought to examine the modifying effect of dietary pattern on the relation between vitamin B-12 intake, biomarkers, and plasma MMA.

Methods

Study population

The study was conducted on participants of the calibration subgroup selected from the larger cohort of 96,194 white and black men and women of the ongoing AHS-2 cohort. AHS-2 was designed to study associations between lifestyle and risk of cancer. Study recruitment and selection methods have been described elsewhere (31). Participants had to be ≥30 y of age for inclusion and blacks were oversampled. The calibration subgroup, also described elsewhere (31), was formed as a representative sample (n = 1011) selected from the parent cohort by church and then by subject-within-church. Participants attended clinics at their local church where anthropometric measurements and fasting blood specimens were collected. Sociodemographic and lifestyle variables including age; sex; race; education; physical activity; cigarette smoking; alcohol use; and use of supplements, drugs, and various medications were assessed by questionnaire. The duration of the calibration substudy was ∼9–12 mo for any one subject. Of the total calibration study sample, 850 participants had a minimum of five of six 24-h recalls and biomarker data. Because impaired clearance of MMA from blood occurs owing to renal dysfunction, we excluded 29 participants with missing creatinine data and 18 participants with serum creatinine >1.47 mg/dL (>130 μmol/L) (32, 33). Also excluded were 3 participants with BMI (in kg/m²) <16 and >60 and 16 participants whose BMI was missing, resulting in a final cohort of 785 participants. All subjects gave written informed consent. The study protocol was approved by the Institutional Review Board of Loma Linda University.

Dietary data

Total vitamin B-12 intakes from foods, fortified foods, and supplements were obtained via 24-h dietary recalls obtained by telephone and the interviews were digitally recorded. Typically a set of 3 recalls were obtained (1 Saturday, 1 Sunday, and 1 weekday) 2 mo before the clinic visits and a second set of 3 (1 Saturday, 1 Sunday, and 1 weekday) ∼6 mo after the clinic visits. Dietary intakes are often rather different on Saturdays, Sundays, and on typical weekdays. Thus, within each of the 2 sets of 24-h recalls, each day was appropriately weighted and summed to produce a synthetic week (Saturday intake + Sunday intake + 5 × weekday intake), then divided by 7 to obtain the mean daily food intake estimate. Further details on adjustments and weighting of dietary recall data have been published (30). The recalls were administered unannounced by telephone by a trained dietitian using standard probes and a multiple-pass methodology. Recall data were entered into a database using the Nutrition Data System for Research version 5.0 of the Nutrition Coordinating Center, Minneapolis, MN.

As described in a previous AHS-2 publication (34), dietary patterns were determined from FFQ data according to reported intake of animal source foods. Thus, individuals defined as vegan consumed meats (including poultry and fish), dairy products, and eggs <1 time/mo; lacto-ovo-vegetarians consumed dairy products and eggs ≥1 time/mo and meats <1 time/mo; pesco-vegetarians consumed fish ≥1 time/wk and other meats <1 time/mo; semivegetarians consumed nonfish meals ≥1 time/mo and all meats ≥1 time/mo but ≤1 time/wk; and nonvegetarians consumed all meats >1 time/wk. Because of small numbers, in this analysis pesco- and semivegetarians were merged with the nonvegetarian group.

Laboratory analyses

Collection and processing of blood after an overnight fast followed standard protocols. Serum was separated from cells within 30 min of collection, placed on wet ice, and shipped or transported to the central study laboratory at Loma Linda, CA for further processing. Blood was divided into aliquots of 0.5-mL samples and immediately stored in liquid nitrogen until analysis. Serum holoTC was measured by enzyme-immunoassay kits from Axis-Shield Diagnostics Ltd and serum vitamin B-12 and Hcy by ELISA kits from Monobind Inc. according to the manufacturer's directions. For holoTC, the mean intrabatch CV was 7.2% and the interbatch CV was 10.0%; for vitamin B-12, the mean intrabatch CV was 3.5% and the interbatch CV was 7.0%; and for Hcy, the mean intrabatch CV was 2.4% and the interbatch CV was 4.3%. MMA was determined in serum by LC-tandem MS stable isotope dilution analysis (Mayo Clinic, Rochester, MN). RBC folate was assayed on washed erythrocytes at the Center for Human Nutrition Biomarker laboratories (University of California, Los Angeles). Erythrocyte folate was assayed using an immunoassay and the automated Immulite Chemiluminescence Immunoassay Analyzer (Siemens Healthcare Diagnostics). For RBC folate, the mean intrabatch CV was 5.2% and the interbatch CV was 7.4%.

Covariates

Selection of covariates was based on univariate analysis and published literature. Age, sex, ethnicity/race, and other demographic characteristics and health behaviors were self-reported. Educational attainment was characterized as ≤12 y of high school or less, compared with >12 y as some college and a bachelor or higher degree as college graduate. Smoking and alcohol use were characterized as “ever” for previous or current smoker or drinker or as “never” smoker or drinker. Dietary sources of vitamin B-12 were determined from food intakes reported in the 24-h recalls as previously described (35). Briefly, animal food sources included all meats, dairy foods, and eggs and fortified foods included all items fortified with vitamin B-12, mainly some ready-to-eat breakfast cereals, meat and dairy alternatives, and nutritional yeasts. Of the 60% of subjects who reported consuming vitamin B-12–containing supplements, about half obtained the vitamin from multivitamin preparations and half from individual preparations containing 50–100 μg vitamin B-12 per dose.

Use of oral diabetic medications or acid-reducers (yes, no) was obtained from the questionnaire administered at baseline. To estimate the prevalence of inadequate vitamin B-12 status, the commonly used cutoffs were applied: serum vitamin B-12 <148 pmol/L; holoTC <35 pmol/L; Hcy >15 μmol/L; and MMA ≥0.27 μmol/L and ≥0.37 μmol/L (2, 18, 26, 36). Owing to the absence of hematocrit values, folate concentrations in washed RBC are reported as nanomoles per gram of hemoglobin and the median value (less than/greater than) of 6.6 nmol/g hemoglobin (equivalent to ∼1400 nmol/L folate in whole blood) was used to calculate the OR for high MMA.

Statistical methods

Tests for differences in subject characteristics, biomarker measures, and intake and sources of vitamin B-12 from foods and supplements between dietary groups were conducted using 1-factor ANOVA and the Kruskal–Wallis test for continuous variables, and χ² test and Fisher's exact test for categorical variables.

Dietary sources of vitamin B-12 intake were energy adjusted by the residual method. Zero intake was partitioned out from energy adjustment. Before adjustment, vitamin B-12 dietary intake was log transformed and then energy-adjusted log vitamin B-12 was back-transformed. Total vitamin B-12 intake was the sum of the energy-adjusted dietary intake and the unadjusted supplementary vitamin B-12 intake. Because the dietary recall data contained 2 synthetic weeks, the repetition allowed the estimation of within-person variance and the correction of coefficients for attenuating effects of random errors in the recalls.

To explore the predictive effect of vitamin B-12 biomarkers and intake on elevated MMA, multivariable logistic regression was conducted to model the likelihood of having MMA ≥0.27 µmol/L, which represents values more commonly found in adults with normal renal function (5). For each variable tested (vitamin B-12 intake, vegetarian dietary pattern, and individual vitamin B-12 biomarkers), we calculated ORs and 95% CIs. In model 1, we included dietary pattern and we quantified vitamin B-12 intake as tertiles of total vitamin B-12 intake (animal source + fortified food + supplements). In model 2, vitamin B-12 intake was partitioned into vitamin B-12 supplement use (yes/no) and intake from food (animal source + fortified). In model 3, we fitted both vitamin B-12 supplement use (yes/no), and dietary vitamin B-12 intake further separated into total intake from food (animal source + fortified) and intake from fortified food, meat, fish, and egg/dairy. All models were adjusted for age (continuous), sex, race (white/black), smoking (never/ever), alcohol (never/ever), medication use (yes/no), and blood creatinine concentrations (continuous).

All biomarkers with skewed distribution values were log transformed. To determine the associations between MMA and each of the vitamin B-12 biomarkers and between MMA and vitamin B-12 intake and supplement use, linear regression models were fitted with the log of MMA as the dependent variable and with each of log serum vitamin B-12, holoTC, Hcy, log RBC folate, and log total vitamin B-12 intake as the predictor. Regression assumptions including normality and linearity were assessed by visual inspection of residual plots (see Supplemental Figure 1). There were no severe violations of the assumptions. Finally, to determine whether dietary pattern may modify the relation between MMA and the biomarkers, we further added dietary pattern and its interaction with each biomarker into each linear regression model. (For plots see Supplemental Figure 2.) All models were adjusted for age (continuous), sex, race (white/black), smoking (never/ever), alcohol (never/ever), medication use (yes/no), and blood creatinine (continuous).

Results

After the exclusion of those with fewer than five 24-h recalls, those with no biomarker values, and those whose serum creatinine was >130 μmol/L, the analytic sample consisted of 785 participants. Of these, 76 were vegan, 221 lacto-ovo-vegetarian, and 488 nonvegetarian. Ages ranged from 29 to 94 y with a mean ± SD age of 58.6 ± 13.3 y. BMI ranged from 16.6 to 54.9 with a mean ± SD BMI of 27.3 ± 6.0.

Table 1 shows selected characteristics by vegetarian status. There were significant differences in age, BMI, race, alcohol use, smoking, and use of oral diabetic medication between the dietary groups. Of the biomarkers tested, median circulating concentrations of Hcy and RBC folate differed significantly between the dietary groups. However, the prevalence of vitamin B-12 deficiency based on serum vitamin B-12 <148 pmol/L, holoTC <35 pmol/L, MMA >0.27 μmol/L, or Hcy >15 μmol/L did not differ by dietary pattern.

TABLE 1.

Characteristics of participants by dietary pattern; the calibration substudy of the Adventist Health Study 2¹

	Vegan	Lacto-ovo-vegetarian	Nonvegetarian, semivegetarian, and pesco-vegetarian	P value²
n	76	221	488
Age, y	64.7 ± 12.4	60.2 ± 13.9	56.9 ± 12.8	<0.001^a
BMI, kg/m²	24.9 ± 5.3	25.2 ± 4.8	28.7 ± 6.1	<0.001^b
Sex, %
Female	72.4	62.0	67.4	0.186^c
Male	27.6	38.0	32.6
Race, %
White	56.6	74.7	48.6	<0.001^c
Black	43.4	25.3	51.4
Education, %
High school or less	29.3	24.1	27.3	0.791^c
Some college	33.3	34.5	35.6
College graduate	37.3	41.4	37.1
Alcohol, %
Never	71.6	73.3	51.1	<0.001^c
Ever	28.4	26.7	48.9
Smoking, %
Never	90.8	88.2	78.7	0.001^c
Ever	9.2	11.8	21.3
Physical activity, min/wk
0	6 (8.0)	43 (20.2)	94 (20.1)	0.002^c
>0–60	21 (28.0)	66 (31.0)	179 (38.3)
>60	48 (64.0)	104 (48.8)	194 (41.5)
Diabetic medication user, %	2.6	5.0	9.8	0.017^c
Acid reducer user, %	3.9	3.6	7.2	0.133^c
Serum vitamin B-12, pmol/L	306 [265–387]	322 [274–401]	316 [269–374]	0.489^b
<148	6 (7.9)	13 (6.1)	20 (4.2)	0.240^c
HoloTC, pmol/L	102 [61–136]	99 [67–129]	94 [66–131]	0.482^b
<35	2 (2.7)	13 (6.0)	26 (5.4)	0.589^d
Methylmalonic acid, μmol/L	0.14 [0.12–0.19]	0.14 [0.11–0.18]	0.13 [0.11–0.18]	0.084^b
≥0.27	8 (10.8)	9 (4.2)	23 (4.8)	0.088^d
≥0.37	3 (4.1)	4 (1.9)	7 (1.5)	0.248^d
Homocysteine, μmol/L	12.0 [10.3–14.2]	11.1 [9.4–12.9]	11.4 [9.3–13.4]	0.046^b
≥15	10 (14.3)	26 (13.1)	66 (15.5)	0.730^d
RBC folate, nmol/g hemoglobin	6.70 [5.46–8.34]	6.88 [5.40–8.60]	6.20 [4.62–7.87]	0.001^b

Open in a new tab

Values are mean ± SD, n (%), or median [IQR] unless otherwise indicated. HoloTC, holotranscobalamin.

P value for differences between dietary patterns: ^a1-factor ANOVA, ^bKruskal–Wallis test, ^cchi-square test, ^dFisher's exact test.

Table 2 shows the median and IQR daily intakes of vitamin B-12 from foods, fortified foods, and supplements by dietary pattern. Although dietary intakes of vitamin B-12 from animal source and fortified foods differed between dietary groups, median vitamin B-12 intake from supplements and total vitamin B-12 intake were not significantly different. However, the prevalence of vitamin B-12 intakes below the Estimated Average Requirement (EAR) of 2.0 μg/d (29) was highest in the vegan and lowest in the nonvegetarian dietary groups.

TABLE 2.

Intake of vitamin B-12 from animal source foods, fortified foods, and supplements by dietary pattern¹

	Vegan	Lacto-ovo-vegetarian	Nonvegetarian, semivegetarian, and pesco-vegetarian	P value²
Dietary source of vitamin B-12
Intake from food (animal source + fortified food), μg/d	3.1 [1.8–5.5]	3.4 [2.1–5.6]	3.7 [2.5–5.4]	0.127^a
Animal source foods, μg/d	0.0 [0.0–0.1]	0.2 [0.1–0.6]	1.1 [0.5–2.1]	<0.001^a
Meat and poultry, μg/d	0.0 [0.0–0.0]	0.0 [0.0–0.0]	0.1 [0.0–0.4]	<0.001^a
Fish, μg/d	0.0 [0.0–0.0]	0.0 [0.0–0.0]	0.0 [0.0–0.4]	<0.001^a
Dairy and egg, μg/d	0.0 [0.0–0.0]	0.17 [0.0–0.5]	0.4 [0.1–0.8]	<0.001^a
Fortified food + nutritional yeast, μg/d	1.9 [1.2–3.0]	1.7 [0.6–3.6]	0.9 [0.2–2.1]	<0.001^a
Intake from supplements (multivitamin, vitamin B-12, etc.), μg/d	1.9 [0.0–48.7]	2.6 [0.0–18.1]	1.5 [0.0–12.3]	0.117^a
Total vitamin B-12 intake (animal source + fortified food + supplements), μg/d	9.4 [2.7–79.3]	6.6 [3.8–26.1]	7.3 [3.7–19.3]	0.638^a
Prevalence of vitamin B-12 intake below EAR
Intake <2.0 μg/d	10 (15.2)	19 (10.6)	26 (6.5)	0.0314^b

Open in a new tab

Values are median [IQR] or n (%) unless otherwise indicated. All dietary sources of vitamin B-12 are energy adjusted using the residual method. EAR, Estimated Average Requirement.

P value for differences between dietary patterns: ^aKruskal–Wallis test, ^bchi-square test.

Supplemental Table 1 presents results of logistic regression analysis stratified by MMA concentration. Age, race, educational level, and blood creatinine concentrations were associated with MMA ≥0.27 μmol/L, but not sex, alcohol use, smoking, or use of oral diabetic medication or acid reducers.

Table 3 presents models of predictors of elevated serum MMA by circulating concentrations of biomarkers, vitamin B-12 intake, and dietary pattern. The adjusted OR of elevated plasma MMA was significantly higher in those with holoTC <35 pmol/L, RBC folate <6.6 nmol/g hemoglobin, and Hcy ≥15 μmol/L. The association between elevated plasma MMA, dietary pattern, and dietary vitamin B-12 intake was examined in 3 models. In model 1, neither of the dietary patterns showed a significant association with elevated MMA although the vegan pattern approached statistical significance. The OR for elevated MMA was lowest for total vitamin B-12 intake in the second tertile comprising an intake of 4.42–14.5 μg/d. In model 2, when vitamin B-12 intake was partitioned into supplement use (yes, no) and food intake, only the third tertile (>4.52 μg/d) approached statistical significance. In model 3, further separating vitamin B-12 consumption from supplement use (yes, no) and from animal source foods, fortified foods, meat and poultry, fish, and dairy and eggs did not show any significant associations for any of the food groups.

TABLE 3.

ORs of elevated circulating MMA ≥0.27 µmol/L (number of cases = 32) by specific concentrations of vitamin B-12 biomarkers, dietary patterns, and amounts of vitamin B-12 intake¹

Variable	OR (95% CI)	P value
Biomarker
Serum vitamin B-12, pmol/L
<148	2.68 (0.83, 7.43)	0.0730
≥148	1.00
HoloTC, pmol/L
<35	9.87 (3.22, 28.64)	<0.0001
≥35	1.00
Homocysteine, μmol/L
<15	1.00
≥15	5.59 (2.47, 12.71)	<0.0001
RBC folate, nmol/g hemoglobin
<6.6	1.00
≥6.6	0.42 (0.19, 0.91)	0.0314
Dietary pattern and vitamin B-12 intake (energy adjusted)
Model 1²^,³
Dietary pattern
Nonvegetarian, semivegetarian, and pesco-vegetarian	1.00
Lacto-ovo-vegetarian	0.65 (0.23, 1.68)	0.3916
Vegan	2.49 (0.90, 6.53)	0.0678
Total vitamin B-12 intake (animal source + fortified food + supplements)⁵
Tertile 1 (<4.42 μg/d)	1.00
Tertile 2 (4.42–14.5 μg/d)	0.31 (0.10, 0.84)	0.0291
Tertile 3 (>14.5 μg/d)	0.59 (0.25, 1.34)	0.2107
Model 2²^,⁴
Vitamin B-12 supplement use
No	1.00
Yes	0.61 (0.29, 1.28)	0.1884
Vitamin B-12 intake from food (animal source + fortified food)⁵
Tertile 1 (<2.66 μg/d)	1.00
Tertile 2 (2.26–4.52 μg/d)	0.96 (0.42, 2.16)	0.9109
Tertile 3 (>4.52 μg/d)	0.35 (0.11, 0.96)	0.0545
Model 3⁵^,⁶
Vitamin B-12 supplement use
No	1.00
Yes	0.62 (0.29, 1.32)	0.2083
Vitamin B-12 intake (animal source food)⁵
Tertile 1 (<0.29 μg/d)	1.00
Tertile 2 (0.29–1.19 μg/d)	0.67 (0.18, 2.52)	0.5524
Tertile 3 (>1.19 μg/d)	0.30 (0.05, 1.74)	0.1844
Vitamin B-12 intake (fortified food)⁵
Tertile 1 (<0.60 μg/d)	1.00
Tertile 2 (0.60–2.03 μg/d)	1.18 (0.46, 3.08)	0.7240
Tertile 3 (>2.03 μg/d)	0.80 (0.30, 2.18)	0.6673
Vitamin B-12 (meat and poultry)⁵
Never	1.00
>0 μg/d	1.35 (0.49, 3.63)	0.8853
Vitamin B-12 intake (fish)
None	1.00
>0 μg/d	0.38 (0.08, 1.26)	0.1499
Vitamin B-12 intake (dairy and egg)⁵
Tertile 1 (<0.10 μg/d)	1.00
Tertile 2 (0.10–0.51 μg/d)	1.09 (0.33, 3.20)	0.8842
Tertile 3 (>0.51 μg/d)	1.61 (0.36, 7.38)	0.5367

Open in a new tab

Separate logistic regression was conducted to model the odds of having elevated MMA (>0.27 µmol/L). For each variable (dichotomized concentration of serum vitamin B-12, holoTC, homocysteine, and RBC folate, vitamin B-12 intake, and dietary pattern), an OR was estimated. HoloTC, holotranscobalamin; MMA, methylmalonic acid.

Models were adjusted for age (continuous), sex, race (white/black), smoking (never/ever), alcohol (never/ever), medication use (yes/no), and blood creatinine (continuous).

Model 1: total vitamin B-12 intake from animal source food plus fortified food plus vitamin B-12 supplements was the only predictor variable.

⁴

Model 2: vitamin B-12 intake divided into dietary supplement intake (yes/no) and dietary intake (animal source plus fortified food) quantified as tertiles was the predictor variable.

⁵

Zero dietary vitamin B-12 intake was partitioned out of energy adjustment. Vitamin B-12 intake was log transformed before adjustment and energy-adjusted dietary log vitamin B-12 was back-transformed. Total vitamin B-12 intake is the sum of energy-adjusted dietary intake and unadjusted supplementary intake.

⁶

Model 3: dietary vitamin B-12 intake further divided into intakes from animal source foods, fortified foods, meat, fish, and egg/dairy was fitted as the predictor variable.

Table 4 presents results from regression models on the associations of individual vitamin B-12 biomarkers and total vitamin B-12 intake with circulating MMA concentrations. Log serum vitamin B-12, holoTC, log RBC folate, log total vitamin B-12 intake, and supplement use (yes) all had significant inverse associations, whereas plasma Hcy had a significant positive association, with log plasma MMA. Supplemental Figure 1 shows plots of the associations.

TABLE 4.

β-Coefficients and SEs from regression models on the associations of individual vitamin B-12 biomarkers, vitamin B-12 intake, and circulating MMA concentrations¹

	β estimate	SE	P value
Model 1
Log serum vitamin B-12, μmol/L	−0.1796	0.0258	<0.0001
HoloTC, pmol/L	−0.0019	0.0003	<0.0001
Hcy, μmol/L	0.0241	0.0038	<0.0001
Log RBC folate	−0.1397	0.0366	0.0015
Log total vitamin B-12 intake (animal source food + fortified food + supplements), μg/d	−0.0630	0.0153	<0.0001
Model 2
Log total vitamin B-12 intake (animal source food + fortified food + supplements), μg/d	−0.0733	0.0282	0.0097
Supplement use: yes	−0.0626	0.0152	<0.0001

Open in a new tab

Separate linear regression models were fitted with log of MMA (μmol/L) as the dependent variable and each variable as a predictor. Models were adjusted for age (continuous), sex, race (white/black), smoking (never/ever), alcohol (never/ever), medication use (yes/no), and blood creatinine (continuous). Hcy, homocysteine; HoloTC, holotranscobalamin; MMA, methylmalonic acid.

Table 5 shows findings of models examining effect modification by dietary pattern on the associations between circulating MMA and biomarkers. The association between log plasma MMA and log serum vitamin B-12 was significantly modified by dietary pattern (P = 0.0157 for interaction), with the vegan pattern showing the strongest negative association compared with the nonvegetarian pattern (P = 0.0051). There was no difference in slope between the lacto-ovo-vegetarian and nonvegetarian patterns. The association between log plasma MMA and plasma Hcy was significantly modified by dietary pattern (P = 0.0019 for interaction). The vegan dietary pattern had a stronger positive association between log plasma MMA and plasma Hcy than did the nonvegetarian pattern (P = 0.0010) and there was no difference in slope between the lacto-ovo-vegetarian and nonvegetarian patterns. Also, the association between dietary pattern and log RBC folate was modified by diet (P = 0.0002 for interaction), with the vegan pattern having a stronger negative association than the nonvegetarian pattern (P < 0.0001), with no difference in slope between the lacto-ovo-vegetarian and nonvegetarian patterns. Supplemental Figure 2 shows plots for these associations.

TABLE 5.

Effect of dietary pattern on the associations between log plasma MMA and log serum vitamin B-12, plasma Hcy, and log RBC folate¹

	Slope (SE)	P value	P-interaction
Model 1²
Vegan	−0.429 (0.090)	<0.0001	0.0157
Lacto-ovo-vegetarian	−0.153 (0.046)	0.0019
Nonvegetarian, semivegetarian, and pesco-vegetarian	−0.160 (0.032)	<0.0001
Model 2³
Vegan	0.071 (0.014)	<0.0001	0.0019
Lacto-ovo-vegetarian	0.018 (0.006)	0.0010
Nonvegetarian, semivegetarian, and pesco-vegetarian	0.023 (0.005)	<0.0001
Model 3⁴
Vegan	−0.547 (0.110)	<0.0001	0.0002
Lacto-ovo-vegetarian	−0.196 (0.014)	0.0036
Nonvegetarian, semivegetarian, and pesco-vegetarian	−0.063 (0.043)	0.0727

Open in a new tab

Models were adjusted for age (continuous), sex, race (white/black), smoking (never/ever), alcohol (never/ever), medication use (yes/no), and blood creatinine (continuous). MMA, methylmalonic acid.

Model 1: effect of the interaction between dietary pattern, log plasma MMA (μmol/L), and log serum vitamin B-12 (pmol/L).

Model 2: effect of the interaction between dietary pattern, log plasma MMA (μmol/L), and plasma Hcy (μmol/L).

⁴

Model 3: effect of the interaction between dietary pattern, log plasma MMA (μmol/L), and log RBC folate (nmol/g hemoglobin).

Discussion

This study presents the prevalence of high plasma MMA and related factors in adult and elderly individuals with no or relatively low-to-moderate intake of animal source foods residing in the United States and Canada. In this cross-sectional study of 785 non-Hispanic white and black participants randomly selected from Adventist churches, 10% were defined as vegan, 28% as lacto-ovo-vegetarian, and the rest as nonvegetarian, with a higher occurrence of vegans and lacto-ovo-vegetarians in whites and never-users of alcohol or tobacco, and a lower occurrence in those who used an oral diabetic medication. The prevalence of high plasma MMA ≥0.27 μmol/L and ≥0.37 μmol/L did not differ by dietary pattern and was comparable with rates in middle-aged and older individuals reported by NHANES (18). Also, the prevalence of vitamin B-12 deficiency assessed by any of the biomarkers did not differ by dietary pattern, in contrast to dietary vitamin B-12 intake derived from multiple 24-h recalls which showed a higher prevalence of intakes below the EAR (<2.0 μg/d) in the vegan (15.2%) and lacto-ovo-vegetarian dietary patterns (10.6%) than in the nonvegetarian (6.5%) dietary pattern.

Our findings support previous observations that elevated plasma MMA increases with age and is less common in those with black ethnicity (18, 26, 33). Because the sensitivity of the biomarkers MMA and Hcy lessens in older individuals owing to impaired renal function (26, 37), individuals with serum creatinine ≥130 μmol/L, a surrogate marker for kidney disease, were excluded from this study and regression analyses were adjusted for creatinine. Unlike some reports (38, 39) and possibly due to the small proportion of individuals reporting usage, high plasma MMA was not associated with use of either oral diabetic medications or acid reducers in our cohort. Consistent with previous findings, plasma MMA was negatively associated with serum vitamin B-12, dietary vitamin B-12 intake from food and supplements (26, 27, 33, 40), and holoTC (27, 40), and positively with plasma Hcy (27). The OR for high plasma MMA was significantly related to holoTC, Hcy, and RBC folate with the strongest OR of 9.87 shown for holoTC. This may be explained by the fact that serum holoTC is the biologically active form of the vitamin, directly involved in binding vitamin B-12 and facilitating its receptor-mediated transport into cells where it is converted to the coenzyme adenosyl-CoA for conversion of methylmalonyl-CoA to succinyl-CoA (4). However, unlike findings from the post–folic acid fortification NHANES population, the OR for high plasma MMA was not significantly higher in those with serum vitamin B-12 <148 pmol/L, or in those using supplements (33). This may be attributed to the inclusion of older adults and elderly in the current study, and it has been observed that the association between dietary vitamin B-12 intake and vitamin B-12 biomarkers weakens with age owing to increasing malabsorption disorders and other age-related influences contributing to reduced bioavailability of the vitamin, especially from animal products, in the elderly (15, 41). Also, the likelihood of high MMA was not related to dietary pattern. The lack of association with dietary pattern may be accounted for by the fact that the mean total daily vitamin B-12 intake derived from food, fortified food, and supplements did not differ by dietary pattern in this cohort.

In our previous study on the same cohort (35), we found plasma vitamin B-12 concentrations to be correlated to vitamin B-12 intake from supplements, fortified foods, and fortified milk alternatives. In the current study, only total daily vitamin B-12 intake from all sources in the second tertile (4.4–14.5 μg/d) reduced the likelihood of elevated MMA, a reduction of ∼69%. That higher vitamin B-12 doses do not affect MMA may be explained by the reduced efficiency of vitamin B-12 absorption at high doses (5). On the other hand, although the current RDA for vitamin B-12 in adults and elderly is 2.4 μg/d (42), studies suggest higher amounts may be needed for functional adequacy. In a cross-sectional study of postmenopausal women, Bor et al. (43) found that a daily vitamin B-12 consumption of 6 μg is necessary to correct all vitamin B-12–related biomarkers including MMA; and in a Dutch elderly population van Wijngaarden et al. (27) estimated that saturation of biomarkers occurs with daily dietary intakes >5 μg vitamin B-12.

A possible explanation as to why intake from any single vitamin B-12–containing animal source food category was not predictive in reducing risk of elevated MMA may be the minimal intake of these food items in our cohort. In this analysis, the median daily dietary intake of vitamin B-12 from all animal products was 0.2 μg/d and 1.1 μg/d in the lacto-ovo-vegetarian and nonvegetarian patterns, respectively. These amounts represent low intakes of dairy products and eggs by lacto-ovo-vegetarians and of all animal source foods by nonvegetarians. This observation is substantiated by FFQ data obtained from the parent AHS-2 cohort (34) which estimated median consumption of dairy in lacto-ovo-vegetarians and of meat in nonvegetarians to be 120 g/d and 59 g/d, respectively, quantities considerably smaller than those consumed by the general population (44).

Our analysis of the association between total vitamin B-12 intake, biomarkers, and circulating MMA showed significant results but small effect sizes. For example, for every 10% increase in serum vitamin B-12, MMA decreased by 1.6%. The association between log total vitamin B-12 intake and log plasma MMA generated a β (−0.06) which is weaker than the β (−0.11) calculated by a meta-analysis of observational studies in the adult and elderly population (45). A doubling of vitamin B-12 intake decreases MMA in plasma by 4.3%, and a doubling of serum vitamin B-12 decreases MMA by 12%, and those who use vitamin B-12–containing supplements have an ∼6% lower MMA than those who do not use supplements. As shown by Bailey et al. (46), the relation between serum vitamin B-12 and plasma MMA is complex, varies with age, and is influenced by extremes of the dietary and plasma vitamin B-12 distributions.

In the current study RBC folate concentrations above the median were associated with an ∼58% reduced likelihood of elevated MMA. Some research suggests that high serum folic acid is related to more pronounced metabolic evidence of vitamin B-12 deficiency (36) and a worsening deficiency in those with low vitamin B-12 status (47). Our findings, based on the reduced form of folate in RBCs rather than on serum concentrations of folic acid, are consistent with NHANES data (18), which also reported a negative association between plasma MMA concentrations and RBC folate. It is likely that many who used vitamin B-12–containing supplements also consumed folic acid, which improved their status of both nutrients. The metabolism of vitamin B-12 and folate is closely intertwined in one-carbon metabolism, but the biological mechanism via which folate appears to reduce the risk of elevated MMA has not been fully explained.

In determining the impact of the various dietary patterns on the relations between dietary vitamin B-12 intake and biomarkers, we found significant effect modification by all 3 dietary patterns on the associations between log plasma MMA and log serum vitamin B-12, Hcy, and log RBC folate, except for RBC folate which was not modified by the nonvegetarian pattern. For all biomarkers, the magnitude of the interaction was strongest with the vegan dietary pattern. Plasma vitamin B-12, RBC folate, and plasma Hcy exhibited an almost 3-fold stronger association with plasma MMA in the vegan dietary pattern than in the other patterns. The biological mechanisms underlying these interactions are unclear. Vitamin B-12 and folate act together in Hcy metabolism and methylation reactions (3) but little is known about the impact of other nutrients and dietary components on this interaction. It has been suggested that nutrient-dense animal food products may provide richer amounts of B vitamins and factors which may have a role in vitamin B-12 function (48). More research is crucial to determining the interactive influence of the whole diet and dietary patterns on vitamin B-12 metabolism and its functional ramifications. It is also important to note that although the mean total daily vitamin B-12 intake did not differ by dietary pattern, the vegan pattern showed the highest prevalence of intakes <2.0 μg/d. This suggests that fortified foods and supplements are insufficiently or infrequently consumed by a number of individuals adhering to the vegan dietary pattern.

An expert panel concluded that the assessment of vitamin B-12 status should include measurement of ≥1 direct indicator such as serum vitamin B-12 and 1 functional marker, preferably plasma MMA (49). The strong association shown in this study between serum vitamin B-12 and the more costly plasma MMA, especially in vegans, confirms the importance of serum vitamin B-12 analysis and dietary recalls and histories, as strategies for assessing and monitoring vitamin B-12 status in vegans and other vulnerable groups with marginal vitamin B-12 intakes.

To the best of our knowledge, the present study is the first to report dietary and biomarker predictors of elevated MMA in individuals with a range of animal food consumption in the United States. The included number of vegans and lacto-ovo-vegetarians provides good estimates of factors related to high circulating MMA in individuals adhering to these dietary patterns. Although the baseline lifestyle questionnaire in this study did not inquire about the length of time participants had adhered to vegetarian diets, subsequent research has shown that the AHS-2 cohort demonstrates reliable and consistent long-term patterns of meat, fish, dairy, and egg intakes (50). Although dietary recalls have inherent limitations related to memory, portion estimation, and completeness, some of these concerns were minimized by the probing protocols and multiple-pass methodology utilized in our digital-based methods. To enhance the reliability of the recalls, dietary intake data were obtained from 2 sets of 3 nonconsecutive 24-h recalls conducted over a time period which closely coincided with that of acquiring the biospecimens. In addition, vitamin B-12 intakes from food, fortified foods, and supplements were corrected for within-person variations and validated accordingly (30).

The study also has limitations and its cross-sectional nature limits conclusions. The bioavailability of vitamin B-12 from various foods and supplements was not accounted for in this analysis. Although individuals with elevated serum creatinine were excluded from the study and the regression models were adjusted for serum creatinine, the creatinine cutoff used may underestimate impaired renal function and the more reliable biomarker cystatin C was not available (51). At the time biochemical tests were conducted, standard reference specimens were not available for serum vitamin B-12 and holoTC quantification so values are appropriate only for within-study comparisons. Also, rare influences on MMA metabolism such as antibodies to intrinsic factor, genetic abnormalities, and polymorphisms were not assessed (8, 52). In addition, the dietary groups in this health-aware cohort may not be representative of all vegetarians with respect to overall dietary intake and lifestyle practices.

Our results indicate that a number of adults and elderly do not achieve dietary vitamin B-12 adequacy. However, it does not inform on dose and frequency of either fortified food intake or supplement use. Owing to the lower bioavailability of food-bound vitamin B-12 in older individuals, the recommendation for adults over the age of 50 y is to meet the RDA for vitamin B-12 of 2.4 μg/d by consuming synthetic vitamin B-12 in vitamin B-12–fortified foods and vitamin B-12 supplements beyond that which is obtained from animal foods (42). The current emphasis on the benefits of eating more plant foods and reducing meat and dairy foods will invariably be accompanied by lower vitamin B-12 intakes among many. Vitamin B-12–fortified foods consist mostly of ready-to-eat cereals and meat and milk alternatives which may not be habitually consumed or preferred by all vegetarians or by those interested in plant-based diets. At present there are no consensus guidelines for the amount and frequency of either fortified food intake or supplemental vitamin B-12 use for those adhering to vegan, lacto-ovo-vegetarian, or plant-based diets. Fortified foods may not provide adequate vitamin B-12 unless consumed in amounts ≥3 servings/d. Suggested daily doses of vitamin B-12 for improving status in those with marginal deficiency range from 50 μg (53) for vegetarians to 1000 μg (54) for the elderly. Given the growing interest in plant-based eating, future studies must seek to determine quantities of supplemental vitamin B-12 and other nutrients required by those who adhere to vegan diets and diets with limited animal source foods.

In conclusion, we have demonstrated a higher prevalence of inadequate vitamin B-12 intake in those adhering to vegan and lacto-ovo-vegetarian dietary patterns compared with nonvegetarian dietary patterns. The likelihood of elevated plasma MMA was reduced by 69% in those whose total dietary vitamin B-12 intake was in the 4.42–14.5 μg/d range. Also, the association between the biomarkers was modified by dietary pattern, with the vegan pattern showing an almost 3-fold stronger association between serum vitamin B-12 and Hcy and plasma MMA. Early detection of vitamin B-12 deficiency is important because the associated neurological symptoms may not be reversible. Our results indicate that serum vitamin B-12 and Hcy are important biomarkers of vitamin B-12 status, particularly in vegans. Inadequate vitamin B-12 intake and status continue to be common in adult and elderly individuals and in those who avoid animal source foods. As the popularity of plant-rich and vegetarian lifestyles increases, the importance of dietary and clinical monitoring of vitamin B-12 status and the encouragement of vitamin B-12 supplementation cannot be overemphasized.

Supplementary Material

nzaa008_Supplementary_Figure_1

Click here for additional data file.^{(367.6KB, pdf)}

nzaa008_Supplementary_Figure_2

Click here for additional data file.^{(293.5KB, pdf)}

nzaa008_Supplementary_Table_1

Click here for additional data file.^{(13.9KB, docx)}

ACKNOWLEDGEMENTS

We acknowledge the fine laboratory work contribution of Lian Liu and Natalie Kazzi in the bioanalyses. The authors’ responsibilities were as follows—EHH and KJ-S: designed the analysis, planned and collected the appropriate data, and drafted the manuscript; KO: conducted the statistical analysis; GEF: designed and conducted the parent study and reviewed and critically appraised the manuscript for content; and all authors: read and approved the final manuscript.

Notes

Supported by NIH/National Cancer Institute award U01CA152939: 2010-38938-20924 (to GEF) and by a McClean Research Endowment of the Center for Nutrition, Healthy Lifestyle and Disease Prevention, Loma Linda University (to EHH).

Author disclosures: the authors report no conflicts of interest.

Supplemental Table 1 and Supplemental Figures 1 and 2 are available from the “Supplementary data” link in the online posting of the article and from the same link in the online table of contents at https://academic.oup.com/cdn/.

Abbreviations used: AHS-2, Adventist Health Study 2; EAR, Estimated Average Requirement; Hcy, homocysteine; holoTC, holotranscobalamin; MMA, methylmalonic acid.

References

1. Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol. 2006;5(11):949–60. [DOI] [PubMed] [Google Scholar]
2. Green R, Allen LH, Bjørke-Monsen AL, Brito A, Guéant JL, Miller JW, Molloy AM, Nexo E, Stabler S, Toh BH et al.. Vitamin B₁₂ deficiency. Nat Rev Disease Primers. 2017;3:17040. [DOI] [PubMed] [Google Scholar]
3. Friso S, Udali S, De Santis D, Choi SW. One-carbon metabolism and epigenetics. Mol Aspects Med. 2017;54:28–36. [DOI] [PubMed] [Google Scholar]
4. Stabler SP. Clinical practice. Vitamin B₁₂ deficiency. N Engl J Med. 2013;368(2):149–60. [DOI] [PubMed] [Google Scholar]
5. Allen LH, Miller JW, de Groot L, Rosenberg IH, Smith AD, Refsum H, Raiten DJ. Biomarkers of Nutrition for Development (BOND): vitamin B-12 review. J Nutr. 2018;148(Suppl_4):1995s–2027s. [DOI] [PMC free article] [PubMed] [Google Scholar]
6. Morath MA, Okun JG, Muller IB, Sauer SW, Horster F, Hoffmann GF, Kolker S. Neurodegeneration and chronic renal failure in methylmalonic aciduria—a pathophysiological approach. J Inherit Metab Dis. 2008;31(1):35–43. [DOI] [PubMed] [Google Scholar]
7. Gabbi P, Ribeiro LR, Jessie Martins G, Cardoso AS, Haupental F, Rodrigues FS, Machado AK, Sperotto Brum J, Medeiros Frescura Duarte MM, Schetinger MR et al.. Methylmalonate induces inflammatory and apoptotic potential: a link to glial activation and neurological dysfunction. J Neuropathol Exp Neurol. 2017;76(3):160–78. [DOI] [PubMed] [Google Scholar]
8. Molloy AM, Pangilinan F, Mills JL, Shane B, O'Neill MB, McGaughey DM, Velkova A, Abaan HO, Ueland PM, McNulty H et al.. A common polymorphism in HIBCH influences methylmalonic acid concentrations in blood independently of cobalamin. Am J Hum Genet. 2016;98(5):869–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
9. Fraser GE. Vegetarian diets: what do we know of their effects on common chronic diseases?. Am J Clin Nutr. 2009;89(5):1607s–12s. [DOI] [PMC free article] [PubMed] [Google Scholar]
10. Tonstad S, Stewart K, Oda K, Batech M, Herring RP, Fraser GE. Vegetarian diets and incidence of diabetes in the Adventist Health Study-2. Nutr Metab Cardiovasc Dis. 2013;23(4):292–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
11. Orlich MJ, Fraser GE. Vegetarian diets in the Adventist Health Study 2: a review of initial published findings. Am J Clin Nutr. 2014;100(Suppl 1):353s–8s. [DOI] [PMC free article] [PubMed] [Google Scholar]
12. Rizzo G, Lagana AS, Rapisarda AM, La Ferrera GM, Buscema M, Rossetti P, Nigro A, Muscia V, Valenti G, Sapia F et al.. Vitamin B12 among vegetarians: status, assessment and supplementation. Nutrients. 2016;8(12):767. [DOI] [PMC free article] [PubMed] [Google Scholar]
13. Morris MS, Selhub J, Jacques PF. Vitamin B-12 and folate status in relation to decline in scores on the Mini-Mental State Examination in the Framingham Heart Study. J Am Geriatr Soc. 2012;60(8):1457–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
14. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr. 2007;85(1):193–200. [DOI] [PMC free article] [PubMed] [Google Scholar]
15. Andres E, Loukili NH, Noel E, Kaltenbach G, Abdelgheni MB, Perrin AE, Noblet-Dick M, Maloisel F, Schlienger JL, Blickle JF. Vitamin B₁₂ (cobalamin) deficiency in elderly patients. CMAJ. 2004;171(3):251–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
16. Pawlak R, Lester SE, Babatunde T. The prevalence of cobalamin deficiency among vegetarians assessed by serum vitamin B12: a review of literature. Eur J Clin Nutr. 2014;68(5):541–8. [DOI] [PubMed] [Google Scholar]
17. Gilsing AM, Crowe FL, Lloyd-Wright Z, Sanders TA, Appleby PN, Allen NE, Key TJ. Serum concentrations of vitamin B12 and folate in British male omnivores, vegetarians and vegans: results from a cross-sectional analysis of the EPIC-Oxford cohort study. Eur J Clin Nutr. 2010;64(9):933–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
18. Bailey RL, Carmel R, Green R, Pfeiffer CM, Cogswell ME, Osterloh JD, Sempos CT, Yetley EA. Monitoring of vitamin B-12 nutritional status in the United States by using plasma methylmalonic acid and serum vitamin B-12. Am J Clin Nutr. 2011;94(2):552–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
19. Gallego-Narbón A, Zapatera B, Álvarez I, Vaquero MP. Methylmalonic acid levels and their relation with cobalamin supplementation in Spanish vegetarians. Plant Foods Hum Nutr. 2018;73(3):166–71. [DOI] [PubMed] [Google Scholar]
20. Rush EC, Chhichhia P, Hinckson E, Nabiryo C. Dietary patterns and vitamin B₁₂ status of migrant Indian preadolescent girls. Eur J Clin Nutr. 2009;63(4):585–7. [DOI] [PubMed] [Google Scholar]
21. Chandyo RK, Ulak M, Sommerfelt H, Schneede J, Ueland PM, Strand TA. Nutritional intake and status of cobalamin and folate among non-pregnant women of reproductive age in Bhaktapur, Nepal. Nutrients. 2018;10(5):639. [DOI] [PMC free article] [PubMed] [Google Scholar]
22. Visentin CE, Masih SP, Plumptre L, Schroder TH, Sohn KJ, Ly A, Lausman AY, Berger H, Croxford R, Lamers Y et al.. Low serum vitamin B-12 concentrations are prevalent in a cohort of pregnant Canadian women. J Nutr. 2016;146(5):1035–42. [DOI] [PubMed] [Google Scholar]
23. Miller DR, Specker BL, Ho ML, Norman EJ. Vitamin B-12 status in a macrobiotic community. Am J Clin Nutr. 1991;53(2):524–9. [DOI] [PubMed] [Google Scholar]
24. Donaldson MS. Metabolic vitamin B₁₂ status on a mostly raw vegan diet with follow-up using tablets, nutritional yeast, or probiotic supplements. Ann Nutr Metab. 2000;44(5–6):229–34. [DOI] [PubMed] [Google Scholar]
25. Haddad EH, Berk LS, Kettering JD, Hubbard RW, Peters WR. Dietary intake and biochemical, hematologic, and immune status of vegans compared with nonvegetarians. Am J Clin Nutr. 1999;70(3 Suppl):586s–93s. [DOI] [PubMed] [Google Scholar]
26. Vogiatzoglou A, Oulhaj A, Smith AD, Nurk E, Drevon CA, Ueland PM, Vollset SE, Tell GS, Refsum H. Determinants of plasma methylmalonic acid in a large population: implications for assessment of vitamin B₁₂ status. Clin Chem. 2009;55(12):2198–206. [DOI] [PubMed] [Google Scholar]
27. van Wijngaarden JP, Dhonukshe-Rutten RAM, Brouwer-Brolsma EM, Enneman AW, Swart KMA, van Dijk SC, In ’t Veld PH, van Schoor NM, van der Velde N, de Jonge R et al.. Vitamin B12 intake and related biomarkers: associations in a Dutch elderly population. J Nutr Health Aging. 2017;21(10):1268–76. [DOI] [PubMed] [Google Scholar]
28. Ganji V, Kafai MR. Population reference values for serum methylmalonic acid concentrations and its relationship with age, sex, race-ethnicity, supplement use, kidney function and serum vitamin B12 in the post-folic acid fortification period. Nutrients. 2018;10(1):74. [DOI] [PMC free article] [PubMed] [Google Scholar]
29. Rizzo NS, Jaceldo-Siegl K, Sabate J, Fraser GE. Nutrient profiles of vegetarian and nonvegetarian dietary patterns. J Acad Nutr Diet. 2013;113(12):1610–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
30. Fraser GE, Jaceldo-Siegl K, Henning SM, Fan J, Knutsen SF, Haddad EH, Sabate J, Beeson WL, Bennett H. Biomarkers of dietary intake are correlated with corresponding measures from repeated dietary recalls and food-frequency questionnaires in the Adventist Health Study-2. J Nutr. 2016;146(3):586–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
31. Butler TL, Fraser GE, Beeson WL, Knutsen SF, Herring RP, Chan J, Sabaté J, Montgomery S, Haddad E, Preston-Martin S et al.. Cohort profile: the Adventist Health Study-2 (AHS-2). Int J Epidemiol. 2008;37(2):260–5. [DOI] [PubMed] [Google Scholar]
32. Hotu C, Bagg W, Collins J, Harwood L, Whalley G, Doughty R, Gamble G, Braatvedt G. A community-based model of care improves blood pressure control and delays progression of proteinuria, left ventricular hypertrophy and diastolic dysfunction in Maori and Pacific patients with type 2 diabetes and chronic kidney disease: a randomized controlled trial. Nephrol Dial Transplant. 2010;25(10):3260–6. [DOI] [PubMed] [Google Scholar]
33. Ganji V, Kafai MR. Population prevalence, attributable risk, and attributable risk percentage for high methylmalonic acid concentrations in the post-folic acid fortification period in the US. Nutr Metab (Lond). 2012;9(1):2. [DOI] [PMC free article] [PubMed] [Google Scholar]
34. Orlich MJ, Jaceldo-Siegl K, Sabaté J, Fan J, Singh PN, Fraser GE. Patterns of food consumption among vegetarians and non-vegetarians. Br J Nutr. 2014;112(10):1644–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
35. Damayanti D, Jaceldo-Siegl K, Beeson WL, Fraser G, Oda K, Haddad EH. Foods and supplements associated with vitamin B₁₂ biomarkers among vegetarian and non-vegetarian participants of the Adventist Health Study-2 (AHS-2) calibration study. Nutrients. 2018;10(6):722. [DOI] [PMC free article] [PubMed] [Google Scholar]
36. Miller JW, Garrod MG, Allen LH, Haan MN, Green R. Metabolic evidence of vitamin B-12 deficiency, including high homocysteine and methylmalonic acid and low holotranscobalamin, is more pronounced in older adults with elevated plasma folate. Am J Clin Nutr. 2009;90(6):1586–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
37. Loikas S, Koskinen P, Irjala K, Löppönen M, Isoaho R, Kivelä SL, Pelliniemi TT. Vitamin B12 deficiency in the aged: a population-based study. Age Ageing. 2007;36(2):177–83. [DOI] [PubMed] [Google Scholar]
38. Miller JW. Proton pump inhibitors, H₂-receptor antagonists, metformin, and vitamin B-12 deficiency: clinical implications. Adv Nutr. 2018;9(4):511S–8S. [DOI] [PMC free article] [PubMed] [Google Scholar]
39. Reinstatler L, Qi YP, Williamson RS, Garn JV, Oakley GP Jr. Association of biochemical B₁₂ deficiency with metformin therapy and vitamin B₁₂ supplements: the National Health and Nutrition Examination Survey, 1999–2006. Diabetes Care. 2012;35(2):327–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
40. Miller JW, Garrod MG, Rockwood AL, Kushnir MM, Allen LH, Haan MN, Green R. Measurement of total vitamin B₁₂ and holotranscobalamin, singly and in combination, in screening for metabolic vitamin B₁₂ deficiency. Clin Chem. 2006;52(2):278–85. [DOI] [PubMed] [Google Scholar]
41. Howard JM, Azen C, Jacobsen DW, Green R, Carmel R. Dietary intake of cobalamin in elderly people who have abnormal serum cobalamin, methylmalonic acid and homocysteine levels. Eur J Clin Nutr. 1998;52(8):582–7. [DOI] [PubMed] [Google Scholar]
42. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for thiamin, riboflavin, niacin, vitamin B₆, folate, vitamin B₁₂, pantothenic acid, biotin, and choline. Washington (DC): National Academies Press; 1998. [PubMed] [Google Scholar]
43. Bor MV, von Castel-Roberts KM, Kauwell GP, Stabler SP, Allen RH, Maneval DR, Bailey LB, Nexo E. Daily intake of 4 to 7 μg dietary vitamin B-12 is associated with steady concentrations of vitamin B-12–related biomarkers in a healthy young population. Am J Clin Nutr. 2010;91(3):571–7. [DOI] [PubMed] [Google Scholar]
44. Pasiakos SM, Agarwal S, Lieberman HR, Fulgoni VL 3rd. Sources and amounts of animal, dairy, and plant protein intake of US adults in 2007–2010. Nutrients. 2015;7(8):7058–69. [DOI] [PMC free article] [PubMed] [Google Scholar]
45. Dullemeijer C, Souverein OW, Doets EL, van der Voet H, van Wijngaarden JP, de Boer WJ, Plada M, Dhonukshe-Rutten RA, In ’t Veld PH, Cavelaars AE et al.. Systematic review with dose-response meta-analyses between vitamin B-12 intake and European Micronutrient Recommendations Aligned's prioritized biomarkers of vitamin B-12 including randomized controlled trials and observational studies in adults and elderly persons. Am J Clin Nutr. 2013;97(2):390–402. [DOI] [PubMed] [Google Scholar]
46. Bailey RL, Durazo-Arvizu EA, Carmel R, Green R, Pfeiffer CM, Sempos CT, Carriquiry A, Yetley EA. Modeling a methylmalonic acid–derived change point for serum vitamin B-12 for adults in NHANES. Am J Clin Nutr. 2013;98(2):460–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
47. Selhub J, Morris MS, Jacques PF. In vitamin B₁₂ deficiency, higher serum folate is associated with increased total homocysteine and methylmalonic acid concentrations. Proc Natl Acad Sci U S A. 2007;104(50):19995–20000. [DOI] [PMC free article] [PubMed] [Google Scholar]
48. Obeid R, Heil SG, Verhoeven MMA, van den Heuvel E, de Groot L, Eussen S. Vitamin B12 intake from animal foods, biomarkers, and health aspects. Front Nutr. 2019;6:93. [DOI] [PMC free article] [PubMed] [Google Scholar]
49. Yetley EA, Pfeiffer CM, Phinney KW, Bailey RL, Blackmore S, Bock JL, Brody LC, Carmel R, Curtin LR, Durazo-Arvizu RA et al.. Biomarkers of vitamin B-12 status in NHANES: a roundtable summary. Am J Clin Nutr. 2011;94(1):313s–21s. [DOI] [PMC free article] [PubMed] [Google Scholar]
50. Singh PN, Batech M, Faed P, Jaceldo-Siegl K, Martins M, Fraser GE. Reliability of meat, fish, dairy, and egg intake over a 33-year interval in Adventist Health Study 2. Nutr Cancer. 2014;66(8):1315–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
51. Fliser D. Assessment of renal function in elderly patients. Curr Opin Nephrol Hypertens. 2008;17(6):604–8. [DOI] [PubMed] [Google Scholar]
52. Baumgartner MR, Horster F, Dionisi-Vici C, Haliloglu G, Karall D, Chapman KA, Huemer M, Hochuli M, Assoun M, Ballhausen D et al.. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis. 2014;9:130. [DOI] [PMC free article] [PubMed] [Google Scholar]
53. Del Bo C, Riso P, Gardana C, Brusamolino A, Battezzati A, Ciappellano S. Effect of two different sublingual dosages of vitamin B₁₂ on cobalamin nutritional status in vegans and vegetarians with a marginal deficiency: a randomized controlled trial. Clin Nutr. 2019;38(2):575–83. [DOI] [PubMed] [Google Scholar]
54. Eussen SJ, de Groot LC, Clarke R, Schneede J, Ueland PM, Hoefnagels WH, van Staveren WA. Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial. Arch Intern Med. 2005;165(10):1167–72. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

nzaa008_Supplementary_Figure_1

Click here for additional data file.^{(367.6KB, pdf)}

nzaa008_Supplementary_Figure_2

Click here for additional data file.^{(293.5KB, pdf)}

nzaa008_Supplementary_Table_1

Click here for additional data file.^{(13.9KB, docx)}

[bib1] 1. Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol. 2006;5(11):949–60. [DOI] [PubMed] [Google Scholar]

[bib2] 2. Green R, Allen LH, Bjørke-Monsen AL, Brito A, Guéant JL, Miller JW, Molloy AM, Nexo E, Stabler S, Toh BH et al.. Vitamin B₁₂ deficiency. Nat Rev Disease Primers. 2017;3:17040. [DOI] [PubMed] [Google Scholar]

[bib3] 3. Friso S, Udali S, De Santis D, Choi SW. One-carbon metabolism and epigenetics. Mol Aspects Med. 2017;54:28–36. [DOI] [PubMed] [Google Scholar]

[bib4] 4. Stabler SP. Clinical practice. Vitamin B₁₂ deficiency. N Engl J Med. 2013;368(2):149–60. [DOI] [PubMed] [Google Scholar]

[bib5] 5. Allen LH, Miller JW, de Groot L, Rosenberg IH, Smith AD, Refsum H, Raiten DJ. Biomarkers of Nutrition for Development (BOND): vitamin B-12 review. J Nutr. 2018;148(Suppl_4):1995s–2027s. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib6] 6. Morath MA, Okun JG, Muller IB, Sauer SW, Horster F, Hoffmann GF, Kolker S. Neurodegeneration and chronic renal failure in methylmalonic aciduria—a pathophysiological approach. J Inherit Metab Dis. 2008;31(1):35–43. [DOI] [PubMed] [Google Scholar]

[bib7] 7. Gabbi P, Ribeiro LR, Jessie Martins G, Cardoso AS, Haupental F, Rodrigues FS, Machado AK, Sperotto Brum J, Medeiros Frescura Duarte MM, Schetinger MR et al.. Methylmalonate induces inflammatory and apoptotic potential: a link to glial activation and neurological dysfunction. J Neuropathol Exp Neurol. 2017;76(3):160–78. [DOI] [PubMed] [Google Scholar]

[bib8] 8. Molloy AM, Pangilinan F, Mills JL, Shane B, O'Neill MB, McGaughey DM, Velkova A, Abaan HO, Ueland PM, McNulty H et al.. A common polymorphism in HIBCH influences methylmalonic acid concentrations in blood independently of cobalamin. Am J Hum Genet. 2016;98(5):869–82. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib9] 9. Fraser GE. Vegetarian diets: what do we know of their effects on common chronic diseases?. Am J Clin Nutr. 2009;89(5):1607s–12s. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib10] 10. Tonstad S, Stewart K, Oda K, Batech M, Herring RP, Fraser GE. Vegetarian diets and incidence of diabetes in the Adventist Health Study-2. Nutr Metab Cardiovasc Dis. 2013;23(4):292–9. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib11] 11. Orlich MJ, Fraser GE. Vegetarian diets in the Adventist Health Study 2: a review of initial published findings. Am J Clin Nutr. 2014;100(Suppl 1):353s–8s. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib12] 12. Rizzo G, Lagana AS, Rapisarda AM, La Ferrera GM, Buscema M, Rossetti P, Nigro A, Muscia V, Valenti G, Sapia F et al.. Vitamin B12 among vegetarians: status, assessment and supplementation. Nutrients. 2016;8(12):767. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib13] 13. Morris MS, Selhub J, Jacques PF. Vitamin B-12 and folate status in relation to decline in scores on the Mini-Mental State Examination in the Framingham Heart Study. J Am Geriatr Soc. 2012;60(8):1457–64. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib14] 14. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr. 2007;85(1):193–200. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib15] 15. Andres E, Loukili NH, Noel E, Kaltenbach G, Abdelgheni MB, Perrin AE, Noblet-Dick M, Maloisel F, Schlienger JL, Blickle JF. Vitamin B₁₂ (cobalamin) deficiency in elderly patients. CMAJ. 2004;171(3):251–9. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib16] 16. Pawlak R, Lester SE, Babatunde T. The prevalence of cobalamin deficiency among vegetarians assessed by serum vitamin B12: a review of literature. Eur J Clin Nutr. 2014;68(5):541–8. [DOI] [PubMed] [Google Scholar]

[bib17] 17. Gilsing AM, Crowe FL, Lloyd-Wright Z, Sanders TA, Appleby PN, Allen NE, Key TJ. Serum concentrations of vitamin B12 and folate in British male omnivores, vegetarians and vegans: results from a cross-sectional analysis of the EPIC-Oxford cohort study. Eur J Clin Nutr. 2010;64(9):933–9. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib18] 18. Bailey RL, Carmel R, Green R, Pfeiffer CM, Cogswell ME, Osterloh JD, Sempos CT, Yetley EA. Monitoring of vitamin B-12 nutritional status in the United States by using plasma methylmalonic acid and serum vitamin B-12. Am J Clin Nutr. 2011;94(2):552–61. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib19] 19. Gallego-Narbón A, Zapatera B, Álvarez I, Vaquero MP. Methylmalonic acid levels and their relation with cobalamin supplementation in Spanish vegetarians. Plant Foods Hum Nutr. 2018;73(3):166–71. [DOI] [PubMed] [Google Scholar]

[bib20] 20. Rush EC, Chhichhia P, Hinckson E, Nabiryo C. Dietary patterns and vitamin B₁₂ status of migrant Indian preadolescent girls. Eur J Clin Nutr. 2009;63(4):585–7. [DOI] [PubMed] [Google Scholar]

[bib21] 21. Chandyo RK, Ulak M, Sommerfelt H, Schneede J, Ueland PM, Strand TA. Nutritional intake and status of cobalamin and folate among non-pregnant women of reproductive age in Bhaktapur, Nepal. Nutrients. 2018;10(5):639. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib22] 22. Visentin CE, Masih SP, Plumptre L, Schroder TH, Sohn KJ, Ly A, Lausman AY, Berger H, Croxford R, Lamers Y et al.. Low serum vitamin B-12 concentrations are prevalent in a cohort of pregnant Canadian women. J Nutr. 2016;146(5):1035–42. [DOI] [PubMed] [Google Scholar]

[bib23] 23. Miller DR, Specker BL, Ho ML, Norman EJ. Vitamin B-12 status in a macrobiotic community. Am J Clin Nutr. 1991;53(2):524–9. [DOI] [PubMed] [Google Scholar]

[bib24] 24. Donaldson MS. Metabolic vitamin B₁₂ status on a mostly raw vegan diet with follow-up using tablets, nutritional yeast, or probiotic supplements. Ann Nutr Metab. 2000;44(5–6):229–34. [DOI] [PubMed] [Google Scholar]

[bib25] 25. Haddad EH, Berk LS, Kettering JD, Hubbard RW, Peters WR. Dietary intake and biochemical, hematologic, and immune status of vegans compared with nonvegetarians. Am J Clin Nutr. 1999;70(3 Suppl):586s–93s. [DOI] [PubMed] [Google Scholar]

[bib26] 26. Vogiatzoglou A, Oulhaj A, Smith AD, Nurk E, Drevon CA, Ueland PM, Vollset SE, Tell GS, Refsum H. Determinants of plasma methylmalonic acid in a large population: implications for assessment of vitamin B₁₂ status. Clin Chem. 2009;55(12):2198–206. [DOI] [PubMed] [Google Scholar]

[bib27] 27. van Wijngaarden JP, Dhonukshe-Rutten RAM, Brouwer-Brolsma EM, Enneman AW, Swart KMA, van Dijk SC, In ’t Veld PH, van Schoor NM, van der Velde N, de Jonge R et al.. Vitamin B12 intake and related biomarkers: associations in a Dutch elderly population. J Nutr Health Aging. 2017;21(10):1268–76. [DOI] [PubMed] [Google Scholar]

[bib28] 28. Ganji V, Kafai MR. Population reference values for serum methylmalonic acid concentrations and its relationship with age, sex, race-ethnicity, supplement use, kidney function and serum vitamin B12 in the post-folic acid fortification period. Nutrients. 2018;10(1):74. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib29] 29. Rizzo NS, Jaceldo-Siegl K, Sabate J, Fraser GE. Nutrient profiles of vegetarian and nonvegetarian dietary patterns. J Acad Nutr Diet. 2013;113(12):1610–19. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib30] 30. Fraser GE, Jaceldo-Siegl K, Henning SM, Fan J, Knutsen SF, Haddad EH, Sabate J, Beeson WL, Bennett H. Biomarkers of dietary intake are correlated with corresponding measures from repeated dietary recalls and food-frequency questionnaires in the Adventist Health Study-2. J Nutr. 2016;146(3):586–94. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib31] 31. Butler TL, Fraser GE, Beeson WL, Knutsen SF, Herring RP, Chan J, Sabaté J, Montgomery S, Haddad E, Preston-Martin S et al.. Cohort profile: the Adventist Health Study-2 (AHS-2). Int J Epidemiol. 2008;37(2):260–5. [DOI] [PubMed] [Google Scholar]

[bib32] 32. Hotu C, Bagg W, Collins J, Harwood L, Whalley G, Doughty R, Gamble G, Braatvedt G. A community-based model of care improves blood pressure control and delays progression of proteinuria, left ventricular hypertrophy and diastolic dysfunction in Maori and Pacific patients with type 2 diabetes and chronic kidney disease: a randomized controlled trial. Nephrol Dial Transplant. 2010;25(10):3260–6. [DOI] [PubMed] [Google Scholar]

[bib33] 33. Ganji V, Kafai MR. Population prevalence, attributable risk, and attributable risk percentage for high methylmalonic acid concentrations in the post-folic acid fortification period in the US. Nutr Metab (Lond). 2012;9(1):2. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib34] 34. Orlich MJ, Jaceldo-Siegl K, Sabaté J, Fan J, Singh PN, Fraser GE. Patterns of food consumption among vegetarians and non-vegetarians. Br J Nutr. 2014;112(10):1644–53. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib35] 35. Damayanti D, Jaceldo-Siegl K, Beeson WL, Fraser G, Oda K, Haddad EH. Foods and supplements associated with vitamin B₁₂ biomarkers among vegetarian and non-vegetarian participants of the Adventist Health Study-2 (AHS-2) calibration study. Nutrients. 2018;10(6):722. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib36] 36. Miller JW, Garrod MG, Allen LH, Haan MN, Green R. Metabolic evidence of vitamin B-12 deficiency, including high homocysteine and methylmalonic acid and low holotranscobalamin, is more pronounced in older adults with elevated plasma folate. Am J Clin Nutr. 2009;90(6):1586–92. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib37] 37. Loikas S, Koskinen P, Irjala K, Löppönen M, Isoaho R, Kivelä SL, Pelliniemi TT. Vitamin B12 deficiency in the aged: a population-based study. Age Ageing. 2007;36(2):177–83. [DOI] [PubMed] [Google Scholar]

[bib38] 38. Miller JW. Proton pump inhibitors, H₂-receptor antagonists, metformin, and vitamin B-12 deficiency: clinical implications. Adv Nutr. 2018;9(4):511S–8S. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib39] 39. Reinstatler L, Qi YP, Williamson RS, Garn JV, Oakley GP Jr. Association of biochemical B₁₂ deficiency with metformin therapy and vitamin B₁₂ supplements: the National Health and Nutrition Examination Survey, 1999–2006. Diabetes Care. 2012;35(2):327–33. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib40] 40. Miller JW, Garrod MG, Rockwood AL, Kushnir MM, Allen LH, Haan MN, Green R. Measurement of total vitamin B₁₂ and holotranscobalamin, singly and in combination, in screening for metabolic vitamin B₁₂ deficiency. Clin Chem. 2006;52(2):278–85. [DOI] [PubMed] [Google Scholar]

[bib41] 41. Howard JM, Azen C, Jacobsen DW, Green R, Carmel R. Dietary intake of cobalamin in elderly people who have abnormal serum cobalamin, methylmalonic acid and homocysteine levels. Eur J Clin Nutr. 1998;52(8):582–7. [DOI] [PubMed] [Google Scholar]

[bib42] 42. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for thiamin, riboflavin, niacin, vitamin B₆, folate, vitamin B₁₂, pantothenic acid, biotin, and choline. Washington (DC): National Academies Press; 1998. [PubMed] [Google Scholar]

[bib43] 43. Bor MV, von Castel-Roberts KM, Kauwell GP, Stabler SP, Allen RH, Maneval DR, Bailey LB, Nexo E. Daily intake of 4 to 7 μg dietary vitamin B-12 is associated with steady concentrations of vitamin B-12–related biomarkers in a healthy young population. Am J Clin Nutr. 2010;91(3):571–7. [DOI] [PubMed] [Google Scholar]

[bib44] 44. Pasiakos SM, Agarwal S, Lieberman HR, Fulgoni VL 3rd. Sources and amounts of animal, dairy, and plant protein intake of US adults in 2007–2010. Nutrients. 2015;7(8):7058–69. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib45] 45. Dullemeijer C, Souverein OW, Doets EL, van der Voet H, van Wijngaarden JP, de Boer WJ, Plada M, Dhonukshe-Rutten RA, In ’t Veld PH, Cavelaars AE et al.. Systematic review with dose-response meta-analyses between vitamin B-12 intake and European Micronutrient Recommendations Aligned's prioritized biomarkers of vitamin B-12 including randomized controlled trials and observational studies in adults and elderly persons. Am J Clin Nutr. 2013;97(2):390–402. [DOI] [PubMed] [Google Scholar]

[bib46] 46. Bailey RL, Durazo-Arvizu EA, Carmel R, Green R, Pfeiffer CM, Sempos CT, Carriquiry A, Yetley EA. Modeling a methylmalonic acid–derived change point for serum vitamin B-12 for adults in NHANES. Am J Clin Nutr. 2013;98(2):460–7. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib47] 47. Selhub J, Morris MS, Jacques PF. In vitamin B₁₂ deficiency, higher serum folate is associated with increased total homocysteine and methylmalonic acid concentrations. Proc Natl Acad Sci U S A. 2007;104(50):19995–20000. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib48] 48. Obeid R, Heil SG, Verhoeven MMA, van den Heuvel E, de Groot L, Eussen S. Vitamin B12 intake from animal foods, biomarkers, and health aspects. Front Nutr. 2019;6:93. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib49] 49. Yetley EA, Pfeiffer CM, Phinney KW, Bailey RL, Blackmore S, Bock JL, Brody LC, Carmel R, Curtin LR, Durazo-Arvizu RA et al.. Biomarkers of vitamin B-12 status in NHANES: a roundtable summary. Am J Clin Nutr. 2011;94(1):313s–21s. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib50] 50. Singh PN, Batech M, Faed P, Jaceldo-Siegl K, Martins M, Fraser GE. Reliability of meat, fish, dairy, and egg intake over a 33-year interval in Adventist Health Study 2. Nutr Cancer. 2014;66(8):1315–21. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib51] 51. Fliser D. Assessment of renal function in elderly patients. Curr Opin Nephrol Hypertens. 2008;17(6):604–8. [DOI] [PubMed] [Google Scholar]

[bib52] 52. Baumgartner MR, Horster F, Dionisi-Vici C, Haliloglu G, Karall D, Chapman KA, Huemer M, Hochuli M, Assoun M, Ballhausen D et al.. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis. 2014;9:130. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib53] 53. Del Bo C, Riso P, Gardana C, Brusamolino A, Battezzati A, Ciappellano S. Effect of two different sublingual dosages of vitamin B₁₂ on cobalamin nutritional status in vegans and vegetarians with a marginal deficiency: a randomized controlled trial. Clin Nutr. 2019;38(2):575–83. [DOI] [PubMed] [Google Scholar]

[bib54] 54. Eussen SJ, de Groot LC, Clarke R, Schneede J, Ueland PM, Hoefnagels WH, van Staveren WA. Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial. Arch Intern Med. 2005;165(10):1167–72. [DOI] [PubMed] [Google Scholar]

PERMALINK

Associations of Circulating Methylmalonic Acid and Vitamin B-12 Biomarkers Are Modified by Vegan Dietary Pattern in Adult and Elderly Participants of the Adventist Health Study 2 Calibration Study

Ella H Haddad

Karen Jaceldo-Siegl

Keiji Oda

Gary E Fraser

ABSTRACT

Background

Objectives

Methods

Results

Conclusions

Introduction

Methods

Study population

Dietary data

Laboratory analyses

Covariates

Statistical methods

Results

TABLE 1.

TABLE 2.

TABLE 3.

TABLE 4.

TABLE 5.

Discussion

Supplementary Material

ACKNOWLEDGEMENTS

Notes

References

Associated Data

Supplementary Materials

ACTIONS

PERMALINK

RESOURCES

Cite

Add to Collections

PERMALINK

Associations of Circulating Methylmalonic Acid and Vitamin B-12 Biomarkers Are Modified by Vegan Dietary Pattern in Adult and Elderly Participants of the Adventist Health Study 2 Calibration Study

Ella H Haddad

Karen Jaceldo-Siegl

Keiji Oda

Gary E Fraser

ABSTRACT

Background

Objectives

Methods

Results

Conclusions

Introduction

Methods

Study population

Dietary data

Laboratory analyses

Covariates

Statistical methods

Results

TABLE 1.

TABLE 2.

TABLE 3.

TABLE 4.

TABLE 5.

Discussion

Supplementary Material

ACKNOWLEDGEMENTS

Notes

References

Associated Data

Supplementary Materials

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases